These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 2328218)
1. The assessment of treatment response in non-Hodgkin's lymphoma by image guided 31P magnetic resonance spectroscopy. Smith SR; Martin PA; Davies JM; Edwards RH; Stevens AN Br J Cancer; 1990 Mar; 61(3):485-90. PubMed ID: 2328218 [TBL] [Abstract][Full Text] [Related]
2. Tumour pH and response to chemotherapy: an in vivo 31P magnetic resonance spectroscopy study in non-Hodgkin's lymphoma. Smith SR; Martin PA; Edwards RH Br J Radiol; 1991 Oct; 64(766):923-8. PubMed ID: 1954534 [TBL] [Abstract][Full Text] [Related]
3. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715 [TBL] [Abstract][Full Text] [Related]
4. In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers. Menon DK; Harris M; Sargentoni J; Taylor-Robinson SD; Cox IJ; Morgan MY Gastroenterology; 1995 Mar; 108(3):776-88. PubMed ID: 7875480 [TBL] [Abstract][Full Text] [Related]
5. Relationship of 31P MR spectroscopy to the histopathological grading of chronic hepatitis and response to therapy. Kiyono K; Shibata A; Sone S; Watanabe T; Oguchi M; Shikama N; Ichijo T; Kiyosawa K; Sodeyama T Acta Radiol; 1998 May; 39(3):309-14. PubMed ID: 9571950 [TBL] [Abstract][Full Text] [Related]
6. Use of phosphorus-31 MR spectroscopy to monitor response to chemotherapy in non-Hodgkin lymphoma. Bryant DJ; Bydder GM; Case HA; Collins AG; Cox IJ; Makepeace A; Pennock JM J Comput Assist Tomogr; 1988; 12(5):770-4. PubMed ID: 3170838 [TBL] [Abstract][Full Text] [Related]
7. [31P-MR spectroscopy of the human liver--the spectral indications of lymphoma infiltration]. Heindel W; du Mesnil de Rochemont R; Kugel H; Ernst S; Tesch H; Diehl V; Lackner K Rofo; 1997 Jul; 167(1):62-70. PubMed ID: 9289045 [TBL] [Abstract][Full Text] [Related]
8. Application of 31P MR spectroscopy to the brain tumors. Ha DH; Choi S; Oh JY; Yoon SK; Kang MJ; Kim KU Korean J Radiol; 2013; 14(3):477-86. PubMed ID: 23690717 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the spleen by in vivo image guided 31P magnetic resonance spectroscopy. Smith SR; Martin PA; Davies JM; Edwards RH NMR Biomed; 1989 Nov; 2(4):172-8. PubMed ID: 2641499 [TBL] [Abstract][Full Text] [Related]
11. Assessment of in situ renal transplant viability by 31P-MRS: experimental study in canines. Bretan PN; Vigneron DB; Hricak H; Price DC; Yen TS; Luo JA; Tanagho EA; James TL Am Surg; 1993 Mar; 59(3):182-7. PubMed ID: 8386489 [TBL] [Abstract][Full Text] [Related]
12. Phosphorus metabolism during growth of lymphoma in mouse liver: a comparison of 31P magnetic resonance spectroscopy in vivo and in vitro. Thomas CP; Dixon RM; Tian M; Butler SA; Counsell CJ; Bradley JK; Adams GE; Radda GK Br J Cancer; 1994 Apr; 69(4):633-40. PubMed ID: 8142251 [TBL] [Abstract][Full Text] [Related]
13. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease. Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496 [TBL] [Abstract][Full Text] [Related]
14. The effects of hypoxia on the bioenergetics of liver in situ in chronic ethanol-treated rats: a noninvasive in vivo 31P magnetic resonance spectroscopy study. Brauer M; Lu W; Ling M J Stud Alcohol; 1997 Mar; 58(2):119-29. PubMed ID: 9065889 [TBL] [Abstract][Full Text] [Related]
15. Abnormal phosphomonoester signals in 31P MR spectra from patients with hepatic lymphoma. A possible marker of liver infiltration and response to chemotherapy. Dixon RM; Angus PW; Rajagopalan B; Radda GK Br J Cancer; 1991 Jun; 63(6):953-8. PubMed ID: 2069850 [TBL] [Abstract][Full Text] [Related]
16. Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy. Dewhirst MW; Poulson JM; Yu D; Sanders L; Lora-Michiels M; Vujaskovic Z; Jones EL; Samulski TV; Powers BE; Brizel DM; Prosnitz LR; Charles HC Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):480-91. PubMed ID: 15667971 [TBL] [Abstract][Full Text] [Related]
17. The total entropy for evaluating 31P-magnetic resonance spectra of the liver in healthy volunteers and patients with metastases. Brinkmann G; Melchert UH; Lalk G; Emde L; Link J; Muhle C; Steffens JC; Heller M Invest Radiol; 1997 Feb; 32(2):100-4. PubMed ID: 9039582 [TBL] [Abstract][Full Text] [Related]
18. Phosphomonoester is associated with proliferation in human breast cancer: a 31P MRS study. Kalra R; Wade KE; Hands L; Styles P; Camplejohn R; Greenall M; Adams GE; Harris AL; Radda GK Br J Cancer; 1993 May; 67(5):1145-53. PubMed ID: 8494715 [TBL] [Abstract][Full Text] [Related]
19. Hepatic cancers and their response to chemoembolization therapy. Quantitative image-guided 31P magnetic resonance spectroscopy. Meyerhoff DJ; Karczmar GS; Valone F; Venook A; Matson GB; Weiner MW Invest Radiol; 1992 Jun; 27(6):456-64. PubMed ID: 1318873 [TBL] [Abstract][Full Text] [Related]